Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-11

Clinical Trial Update: Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at the University of British Columbia is evaluating rapid micro-induction versus standard induction of buprenorphine/naloxone for opioi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: University of British Columbia | Conditions: Opioid Use Disorder | Phase 2 | Status: RECRUITING